Naples

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Lung cancer2 trials
• Asthma1 trial
• Head and neck cancer1 trial
• Hepatitis B1 trial
• Primary biliary cholangitis1 trial
• Triple-negative breast cancer1 trial

Phase

• Phase 23 trials
• Phase 33 trials
• Phase 11 trial

Status

• Active, not recruiting5 trials
• Completed2 trials

Lead sponsor

• GlaxoSmithKline6 trials
• Tesaro, Inc.1 trial

Running trials

• Active, not recruiting

  A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)

  NCT06537414· Phase 2· GlaxoSmithKline· Source

• Active, not recruiting

  A Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants With PD-L1 Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck- GALAXIES H&N-202

  NCT06062420· Phase 2· GlaxoSmithKline· Source

• Active, not recruiting

  Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer Susceptibility Gene Mutation (BRCAmut) or Triple-Negative Breast Cancer (TNBC) With Molecular Disease

  NCT04915755· Phase 3· GlaxoSmithKline· Source

• Active, not recruiting

  Linerixibat Long-term Safety, and Tolerability Study

  NCT04167358· Phase 3· GlaxoSmithKline· Source

• Active, not recruiting

  Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors

  NCT02715284· Phase 1· Tesaro, Inc.· Source

Closed trials

• Completed

  Efficacy and Safety of Depemokimab (GSK3511294) in Participants With Chronic Rhinosinusitis With Nasal Polyps (ANCHOR-2)

  NCT05281523· Phase 3· GlaxoSmithKline· Source

• Completed

  Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC)

  NCT03739710· Phase 2· GlaxoSmithKline· Source